Search results
Labcorp nets companion diagnostic approval for Pfizer’s hemophilia B gene therapy Beqvez
FierceBiotech· 1 day agoThe FDA has bestowed a green light to a companion diagnostic for Pfizer’s recently approved...
Compass Therapeutics Receives FDA Fast Track Designation for the Investigation of CTX-009 in...
Morningstar· 5 days agoCompass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple ...
GV20 Therapeutics Announces Publication in Cell Highlighting the Discovery of IGSF8 as an Innate...
CBS 47 Fresno· 6 days agoGV20 Therapeutics, a clinical-stage biotechnology company integrating AI, genomics, and cancer biology to create next-generation antibody therapeutics, today announced the ...
US FDA grants full approval for Pfizer's cervical cancer drug
AOL· 1 day agoThe treatment, Tivdak - an antibody-drug conjugate co-developed by Genmab A/S and Seagen - received the FDA's accelerated approval for the same indication in 2021. It was ...
FDA grants full approval for Pfizer's cervical cancer drug
New Hampshire Union Leader· 24 hours agoThe treatment, Tivdak -- an antibody-drug conjugate co-developed by Genmab A/S and Seagen --...
AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval
Pharmaceutical Technology via Yahoo Finance· 1 day agoFasenra is a monoclonal antibody that inhibits the alpha subunit of the interleukin-5 receptor found...
Quadruplet Shows 'Excellent Activity' in Myeloma Patients Who Defer HSCT
MedPage Today· 5 days agoAdding the CD38 monoclonal antibody isatuximab (Sarclisa) to a backbone of carfilzomib (Kyprolis),...
Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks via Yahoo Finance· 5 hours agoPipeline Updates Incyte has a collaboration and license agreement with Syndax Pharmaceuticals SNDX...
Tharimmune To Participate in Two Upcoming Investor Conferences in May
Digital Journal· 8 hours agoTharimmune has a license agreement with OmniAb, Inc. to access the company's antibody discovery technology platform against these and other specified targets. For more information ...
BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
KAMR Amarillo· 10 hours agoBio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Dr. Judith Klimovsky to serve as an independent director on the Company's Board of Directors, April 24, 2024. Dr. Klimovsky ...